Understanding the 30-day mortality burden after revision total knee arthroplasty
Background: In revision total knee arthroplasty (TKA), information regarding perioperative mortality risk is essential for careful decision-making. This study aimed to elucidate the (1) overall 30-day mortality rate and (2) 30-day mortality rate stratified by age, comorbidity, and septic vs aseptic...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ff27fd0d7cdf4e5691bb081c614780ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ff27fd0d7cdf4e5691bb081c614780ad |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ff27fd0d7cdf4e5691bb081c614780ad2021-11-14T04:34:07ZUnderstanding the 30-day mortality burden after revision total knee arthroplasty2352-344110.1016/j.artd.2021.08.019https://doaj.org/article/ff27fd0d7cdf4e5691bb081c614780ad2021-10-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2352344121001606https://doaj.org/toc/2352-3441Background: In revision total knee arthroplasty (TKA), information regarding perioperative mortality risk is essential for careful decision-making. This study aimed to elucidate the (1) overall 30-day mortality rate and (2) 30-day mortality rate stratified by age, comorbidity, and septic vs aseptic failure after revision TKA. Methods: The American College of Surgeons National Surgical Quality Improvement Program was reviewed for all patients undergoing revision TKA from 2011 to 2019. A total of 32,354 patients who underwent TKA were identified and categorized as mortality (n = 115) or mortality-free (n = 32,239). Patient characteristics were compared between cohorts and further stratified by septic and aseptic failure. Results: The overall 30-day mortality rate was 0.36%. The percentage of deaths per age group (normalized per 1000) was 0% (18-29 years), 0% (30-39 years), 0.18% (40-49 years), 0.13% (50-59 years), 0.14% (60-69 years), 0.40% (70-79 years), 1.25% (80-89 years), and 6.93% (90+ years). The percentage of deaths per American Society of Anesthesiologists (ASA) class was 0.30% (ASA 1), 0.06% (ASA 2), 0.39% (ASA 3), 2.41% (ASA 4), and 14.29% (ASA 5). Septic revision (P < .001), general anesthesia (P < .001), body mass index ≤ 24.9 (P < .001), and insulin-dependent diabetes (P = .039) were associated with an increased risk of mortality. Conclusions: Increasing age, greater comorbidity burden, underweight or normal body mass index, insulin-dependent diabetes, septic revision, and general anesthesia were all associated with an increased risk of mortality after revision TKA. Notably, 1 in 80 patients aged 80-89 years died after revision TKA compared to 1 in 720 patients aged 60-69 years. Patients who underwent septic revision had a 4-fold increase in mortality compared to aseptic revision. Our stratified assessment of mortality provides a more individualized estimation of risk that can be used for patient counseling in revision TKA.SaTia T. Sinclair, DO, MPHMelissa N. Orr, BSChristopher A. Rothfusz, BSAlison K. Klika, MSJohn P. McLaughlin, DONicolas S. Piuzzi, MDElsevierarticleRevision total knee arthroplastyTotal knee arthroplastyMortalityRisk assessmentOrthopedic surgeryRD701-811ENArthroplasty Today, Vol 11, Iss , Pp 205-211 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Revision total knee arthroplasty Total knee arthroplasty Mortality Risk assessment Orthopedic surgery RD701-811 |
spellingShingle |
Revision total knee arthroplasty Total knee arthroplasty Mortality Risk assessment Orthopedic surgery RD701-811 SaTia T. Sinclair, DO, MPH Melissa N. Orr, BS Christopher A. Rothfusz, BS Alison K. Klika, MS John P. McLaughlin, DO Nicolas S. Piuzzi, MD Understanding the 30-day mortality burden after revision total knee arthroplasty |
description |
Background: In revision total knee arthroplasty (TKA), information regarding perioperative mortality risk is essential for careful decision-making. This study aimed to elucidate the (1) overall 30-day mortality rate and (2) 30-day mortality rate stratified by age, comorbidity, and septic vs aseptic failure after revision TKA. Methods: The American College of Surgeons National Surgical Quality Improvement Program was reviewed for all patients undergoing revision TKA from 2011 to 2019. A total of 32,354 patients who underwent TKA were identified and categorized as mortality (n = 115) or mortality-free (n = 32,239). Patient characteristics were compared between cohorts and further stratified by septic and aseptic failure. Results: The overall 30-day mortality rate was 0.36%. The percentage of deaths per age group (normalized per 1000) was 0% (18-29 years), 0% (30-39 years), 0.18% (40-49 years), 0.13% (50-59 years), 0.14% (60-69 years), 0.40% (70-79 years), 1.25% (80-89 years), and 6.93% (90+ years). The percentage of deaths per American Society of Anesthesiologists (ASA) class was 0.30% (ASA 1), 0.06% (ASA 2), 0.39% (ASA 3), 2.41% (ASA 4), and 14.29% (ASA 5). Septic revision (P < .001), general anesthesia (P < .001), body mass index ≤ 24.9 (P < .001), and insulin-dependent diabetes (P = .039) were associated with an increased risk of mortality. Conclusions: Increasing age, greater comorbidity burden, underweight or normal body mass index, insulin-dependent diabetes, septic revision, and general anesthesia were all associated with an increased risk of mortality after revision TKA. Notably, 1 in 80 patients aged 80-89 years died after revision TKA compared to 1 in 720 patients aged 60-69 years. Patients who underwent septic revision had a 4-fold increase in mortality compared to aseptic revision. Our stratified assessment of mortality provides a more individualized estimation of risk that can be used for patient counseling in revision TKA. |
format |
article |
author |
SaTia T. Sinclair, DO, MPH Melissa N. Orr, BS Christopher A. Rothfusz, BS Alison K. Klika, MS John P. McLaughlin, DO Nicolas S. Piuzzi, MD |
author_facet |
SaTia T. Sinclair, DO, MPH Melissa N. Orr, BS Christopher A. Rothfusz, BS Alison K. Klika, MS John P. McLaughlin, DO Nicolas S. Piuzzi, MD |
author_sort |
SaTia T. Sinclair, DO, MPH |
title |
Understanding the 30-day mortality burden after revision total knee arthroplasty |
title_short |
Understanding the 30-day mortality burden after revision total knee arthroplasty |
title_full |
Understanding the 30-day mortality burden after revision total knee arthroplasty |
title_fullStr |
Understanding the 30-day mortality burden after revision total knee arthroplasty |
title_full_unstemmed |
Understanding the 30-day mortality burden after revision total knee arthroplasty |
title_sort |
understanding the 30-day mortality burden after revision total knee arthroplasty |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/ff27fd0d7cdf4e5691bb081c614780ad |
work_keys_str_mv |
AT satiatsinclairdomph understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty AT melissanorrbs understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty AT christopherarothfuszbs understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty AT alisonkklikams understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty AT johnpmclaughlindo understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty AT nicolasspiuzzimd understandingthe30daymortalityburdenafterrevisiontotalkneearthroplasty |
_version_ |
1718429996320555008 |